Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc
Open Access
- 20 September 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 92 (3) , 466-475
Abstract
Hyperhomocysteinaemia is an independent risk factor for atherosclerotic vascular disease and is associated with vascular endothelial dysfunction. Homocysteine modulates cellular methylation reactions. P66shc is a protein that promotes oxidative stress whose expression is governed by promoter methylation. We asked if homocysteine induces endothelial p66shc expression via hypomethylation of CpG dinucleotides in the p66shc promoter, and whether p66shc mediates homocysteine-stimulated endothelial cell dysfunction. Homocysteine stimulates p66shc transcription in human endothelial cells and hypomethylates specific CpG dinucleotides in the human p66shc promoter. Knockdown of p66shc inhibits the increase in reactive oxygen species, and decrease in nitric oxide, elicited by homocysteine in endothelial cells and prevents homocysteine-induced up-regulation of endothelial intercellular adhesion molecule-1. In addition, knockdown of p66shc mitigates homocysteine-induced adhesion of monocytes to endothelial cells. Inhibition of DNA methyltransferase activity or knockdown of DNA methyltransferase 3b abrogates homocysteine-induced up-regulation of p66shc. Comparison of plasma homocysteine in humans with coronary artery disease shows a significant difference between those with highest and lowest p66shc promoter CpG methylation in peripheral blood leucocytes. Homocysteine up-regulates human p66shc expression via hypomethylation of specific CpG dinucleotides in the p66shc promoter, and this mechanism is important in homocysteine-induced endothelial cell dysfunction.Keywords
This publication has 48 references indexed in Scilit:
- Homocysteine Suppresses the Expression of the Collagen Cross-linker Lysyl Oxidase Involving IL-6, Fli1, and Epigenetic DNA MethylationJournal of Biological Chemistry, 2011
- Epigenetic mechanisms for silencing glutathione S‐transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancerCancer, 2011
- Decreased DNA Methyltransferase 3A and 3B mRNA Expression in Peripheral Blood Mononuclear Cells and Increased Plasma SAH Concentration in Adult Patients with Idiopathic Thrombocytopenic PurpuraJournal of Clinical Immunology, 2008
- Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin AgeneBlood, 2007
- Decreased p66Shc promoter methylation in patients with end-stage renal diseaseClinical Chemistry and Laboratory Medicine (CCLM), 2007
- Expression in T-cells of the proapoptotic protein p66SHC is controlled by promoter demethylationBiochemical and Biophysical Research Communications, 2006
- Profound Flanking Sequence Preference of Dnmt3a and Dnmt3b Mammalian DNA Methyltransferases Shape the Human EpigenomeJournal of Molecular Biology, 2005
- Hyperhomocysteinemia, Oxidative Stress, and Cerebral Vascular DysfunctionStroke, 2004
- The p66Shc Longevity Gene Is Silenced through Epigenetic Modifications of an Alternative PromoterJournal of Biological Chemistry, 2002
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002